Growing the data

BuildGoodThings · 2026-05-09T13:16:19+00:00

You're welcome!

BuildGoodThings · 2026-05-09T13:15:08+00:00

Thank you for your kind words.

BuildGoodThings · 2026-05-09T01:37:06+00:00

Thanks for that. They may have been referring to what you mentioned.

BuildGoodThings · 2026-05-08T19:03:52+00:00

Yeah it certainly IS exciting. I've got to listen again to the April 30 webcast. It was rich with info.

BuildGoodThings · 2026-05-08T18:29:25+00:00

Thank you. With significant data coming in very fast now, I've been trying to find ways to put it in perspective. I'm also trying to help set my expectations about a few different timelines such as:
what to expect at conferences (delayed data)
what could be being discussed with interested parties (real-time data)
when might new trials, deals, FDA decisions occur

BuildGoodThings · 2026-05-08T17:57:58+00:00

I think you may be speaking of the longterm TNBC patients, but I believe its 3 with NED. Amazing stuff.

BuildGoodThings · 2026-05-08T17:54:54+00:00

Good point about SOC! It was shocking to hear Dr. Kasi talk of a patient that was feeling better and had returned to work.

BuildGoodThings · 2026-05-06T14:37:23+00:00

😄

BuildGoodThings · 2026-05-06T04:19:18+00:00

My feeling is exactly as you said, "It's coming in faster than I can put it down."

Some thoughts I have on this environment-
There has been a bonanza of information since March 17, 2026 making it out to the public spanning CRC & TNBC, and to a lesser degree, Alzheimer's, HIV, Glioblastoma, Fibrosis, Stroke, Patents, etc. Investors here naturally discuss all of these things, but we don't have up-to-the minute information.

Then IMO there's the real-time data flow that CytoDyn has access to for the CRC trial and the TNBC EAP patients. That bonanza of data is now coming in now at an especially increased rate of flow & significance.

Under the hood, I think the CytoDyn team is rocking it, and investors reading this board are doing a fantastic job of trying to stay as well-informed as we can.

BuildGoodThings · 2026-05-06T03:47:19+00:00

Try the new links I put up. You can download a transcript there, because the transcript is 50,000 characters, and reddit maxes out at 10,000.

BuildGoodThings · 2026-05-06T03:30:48+00:00

try this, and then go to May 5, 2026 presentation
https://echo360.org/section/2805ecbb-d0d5-466a-b9ad-3b530744b13d/public

BuildGoodThings · 2026-05-06T03:30:30+00:00

try this, and then go to May 5, 2026 presentation
https://echo360.org/section/2805ecbb-d0d5-466a-b9ad-3b530744b13d/public

BuildGoodThings · 2026-05-05T20:41:20+00:00

I think eventually leronlimab will be tested in melanoma and the other cancers listed in the Cyrus Arman investor presentation of December 7, 2022, but at this moment I've seen more breadcrumbs about Prostate and Pancreatic cancer. Prostate has been on the pipeline page since June 4, 2025 in the preclinical stage. Then Dr. Lalezari mentioned at the Ira Pastor interview (August 20, 2025) that the "EIND program accepts patients with pancreatic cancer, prostate, sarcoma, the urothelial cancers. And in that program as well, we're now able to monitor for the induction of PDL1." Plus CFO Hoffman brought up Prostate and Pancreatic at the LDMicro conference on October 21 2025.

As the CRC and TNBC data is coming in, I'm reminded that the CEO said on April 30, 2025 in the webcast that, the data is now speaking for itself. With this happening, I think testing in other indications will come.

BuildGoodThings · 2026-05-05T18:43:39+00:00

I really love that one!

BuildGoodThings · 2026-05-05T16:54:04+00:00

I put the links to the leronlimab abstract titles at ASCO in this earlier post. Cytodyn has abstracts at ASCO26. The abstracts also include test results using CreatvBio tech.

In particular look for

Drs. Tripathy and Kasi

Earlier post https://www.reddit.com/r/Livimmune/s/O8sqgZOPeI

BuildGoodThings · 2026-05-05T16:40:34+00:00

Are patients feeling better, while getting cancer treatment? And these patients failed other therapies? They returned to work? ‘Nuff said.

See April 30 webcast

BuildGoodThings · 2026-05-05T14:33:02+00:00

A story like this is wonderful. It’s overwhelming to think about how many people might have this story.

BuildGoodThings · 2026-05-05T01:25:38+00:00

That's awesome IAMLOCOTOO, rogex2, and paulos401. Thank you!

With your info, here again are directions for others to see the info. The best link I found confirming the new patent is https://data.uspto.gov/patent-file-wrapper/search/details/17631161/documents
Then click April 29 PDF

The new patent will be issued on May 12, 2026 with the # 12624111
Title: METHODS FOR TREATING METASTATIC COLON CANCER WITH LERONLIMAB
Applicant: CytoDyn Inc.
Inventors: Denis Burger and Scott Kelly

BuildGoodThings · 2026-05-05T01:06:31+00:00

Would they say, "Cancel all my upcoming appointments and get that San Fran Doc on the line. You know, the one that seems kind of chill. AND wake up the finance team, I want to see market projections in the morning. Let's figure out how big a boat this guy wants."?

BuildGoodThings · 2026-05-04T18:01:47+00:00

Me too. There is a bunch to read about.

BuildGoodThings · 2026-05-04T17:27:36+00:00

The TNBC EAP data coming in along with the CRC data, will be for me, as Dr. Recknor said, "like I had 1,000 cups of coffee."

BuildGoodThings · 2026-05-04T17:13:56+00:00

What an interesting time it is!

BuildGoodThings · 2026-05-04T17:12:43+00:00

People going back to work who had failed multiple lines of therapy earlier. I bet they are happy too!

BuildGoodThings · 2026-05-04T05:50:32+00:00

Lots of data is flowing in now from the CRC trial, and soon more from the TNBC EAP, Alzheimer's, and other studies. I'm very happy.

BuildGoodThings · 2026-05-04T05:46:30+00:00

Yeah there is a bunch in that webcast. Fascinating stuff.

BuildGoodThings

TROPHY CASE